Oryzon Genomics SA banner

Oryzon Genomics SA
LSE:0RDB

Watchlist Manager
Oryzon Genomics SA Logo
Oryzon Genomics SA
LSE:0RDB
Watchlist
Price: 2.776 EUR 0.87% Market Closed
Market Cap: €221.8m

Wall St Price Targets

0RDB Price Targets Summary
Oryzon Genomics SA

Wall Street analysts forecast 0RDB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 0RDB is 8.291 EUR with a low forecast of 5.323 EUR and a high forecast of 12.771 EUR.

Lowest Forecast
Price Target
5.323 EUR
92% Upside
Average Forecast
Price Target
8.291 EUR
199% Upside
Highest Forecast
Price Target
12.771 EUR
360% Upside
Oryzon Genomics SA Competitors:
Price Targets
PWP
Perella Weinberg Partners
19% Upside

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-43%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-43%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-47%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-47%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 0RDB's stock price target?
Price Target
8.291 EUR

According to Wall Street analysts, the average 1-year price target for 0RDB is 8.291 EUR with a low forecast of 5.323 EUR and a high forecast of 12.771 EUR.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett